Delivery Order SPE2DB22D3016-SPE2DB25FBDW5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $92,418.76 to AmerisourceBergen Drug Corp for the supply of Sandostatin LAR Depot 20 mg kits. This firm fixed-price, competitively awarded delivery order was issued on September 15, 2025, with an ultimate completion date of September 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $8,146.73 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 30 mg kits, with an ultimate completion date of August 22, 2025. This non-set-aside award represents a competitive procurement executed on August 21, 2025, with performance based in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $20,024.51 to AmerisourceBergen Drug Corp for the supply of Sandostatin LAR Depot 30 mg kits under a firm fixed price contract. The award, issued on August 18, 2025, represents a competitively awarded, non-set-aside procurement with an ultimate completion date of August 19, 2025. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a $12,832.80 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Sandostatin LAR Depot 30 mg kits. Scheduled for completion by September 17, 2025, this firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The award was made through open competition with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency's Medical Supply Chain awarded a $10,639.28 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for Sandostatin LAR Depot 20 mg kits, with performance completion targeted for July 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $31,454.05 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 30 mg kits, with an ultimate completion date of August 28, 2025. This non-set-aside contract represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The product will be performed at...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $26,598.20 to AmerisourceBergen Drug Corp for the supply of Sandostatin LAR Depot 20 mg kits. This competitively awarded, firm fixed-price delivery order was issued on September 11, 2025, with an ultimate completion date of September 12, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which...
- The Defense Logistics Agency awarded a delivery order valued at $7,965.76 to AmerisourceBergen Drug Corp for the supply of Sandostatin LAR Depot 30 mg kits. The contract, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a $14,833.72 delivery order to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 30 mg kits under a firm fixed price contract. The award, made on June 26, 2025, represents a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This award involved no set-aside designation and was competitively awarded...
- The Defense Logistics Agency awarded a delivery order valued at $84,445.34 to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 30 mg kits on September 17, 2025, with completion scheduled for September 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a small-value transaction within AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The pharmaceutical product will be performed at the...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBDW5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $19,336.91 to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 30 mg kits under a firm fixed price contract. This non-competitive delivery order was executed on August 4, 2025, with an ultimate completion date of August 5, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled the delivery requirement from its corporate office location in the same city. This delivery order represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a global pharmaceutical support vehicle enabling the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Sandostatin LAR Depot, an octreotide acetate formulation, is a specialty pharmaceutical product commonly used in endocrine and oncology care, reflecting the contractor's role in supplying specialized medical commodities to federal healthcare systems including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.3k | 8/4/25 |